CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

Homepage / GOBIVAZ ® ▼ golimumab (50 mg solution for injection in pre-filled pen;100 mg solution for injection in pre-filled pen; 50 mg solution for injection in pre-filled syringe)

GOBIVAZ ® ▼ golimumab (50 mg solution for injection in pre-filled pen;100 mg solution for injection in pre-filled pen; 50 mg solution for injection in pre-filled syringe)

Information

2025-11-13

Adverse events should be reported. Reporting forms and information for the UK can be found at https://yellowcard.mhra.gov.uk/ and also report using the Yellow Card app. The app is available to download from the Apple App Store, or Google Play Store and you can use your Yellow Card website account details on the app to report. Adverse events should also be reported to ADVANZ PHARMA Medical Information via telephone on +44 (0) 208 588 9131 or via e-mail at medicalinformation@advanzpharma.com

Country Selector

GOBIVAZ ® ▼ golimumab (50 mg solution for injection in pre-filled pen;100 mg solution for injection in pre-filled pen; 50 mg solution for injection in pre-filled syringe)

Information

#{title}